Home|Journals|Articles by Year|Audio Abstracts
 

Case Report

EJMCR. 2021; 5(12): 330-333


A rare case of Merkel cell carcinoma presenting with an upper gastrointestinal bleed: a case report

Georgina Simpson, Kalliopi Alexandropoulou, Panagiotis Koliou, Izhar Bagwan, Christopher Alexakis.




Abstract
Cited by 0 Articles

Background: Merkel cell carcinoma is a rare skin malignancy of neuroendocrine origin that is highly aggressive and frequently metastasizes.
Case Presentation: We present a case of Merkel cell carcinoma in which the patient developed metastatic gastric deposits that led to his admission to the acute medical unit with signs consistent with an upper gastrointestinal bleed. Treatment options in this case were limited to palliative radiotherapy (RT) given the patientÂ’s multimorbid state. Unfortunately, our patient deteriorated during his admission and passed away.
Conclusion: There have been few reports of Merkel cell carcinoma metastasizing to the stomach. In this case, we highlight an immediately life-threatening presentation with upper gastrointestinal bleeding that required prompt endoscopic intervention. The relatively recent initiation of immunotherapy as a management option for this underlying condition introduces a shift in treatment options that were previously limited to RT and chemotherapy.

Key words: Case report, Merkel cell carcinoma, immunotherapy, metastasis, endoscopy






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.